AptarGroup Q2 Earnings Beat Estimates on Pharma & Beverage Growth

ATR tops Q2 earnings and revenue estimates as pharma and beverage growth lift quarterly revenues above $1B for the first time despite margin pressure.

Zacks Investment Research • Aug 5, 2026

Why AptarGroup (ATR) International Revenue Trends Deserve Your Attention

Review AptarGroup's (ATR) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

Zacks Investment Research • Aug 3, 2026

AptarGroup Q2 Earnings Call Highlights

AptarGroup NYSE: ATR reported second-quarter sales growth across each of its three segments and adjusted earnings per share above its guidance range, supported by stronger-than-expected performance in its Pharma business. The company also said President and CEO Stephan Tanda will retire later this year, with President and CEO Designate Gael Touya set to assume the CEO role on Sept.

MarketBeat • Jul 31, 2026

AptarGroup, Inc. (ATR) Q2 2026 Earnings Call Transcript

AptarGroup, Inc. (ATR) Q2 2026 Earnings Call Transcript

Seeking Alpha • Jul 31, 2026

AptarGroup (ATR) Tops Q2 Earnings and Revenue Estimates

AptarGroup (ATR) came out with quarterly earnings of $1.42 per share, beating the Zacks Consensus Estimate of $1.34 per share. This compares to earnings of $1.66 per share a year ago.

Zacks Investment Research • Jul 31, 2026

Aptar Named One of the World's Most Sustainable Companies by TIME for Third Consecutive Year

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it has been named one of the World's Most Sustainable Companies 2026 by TIME for the third consecutive year. Aptar is ranked 261 out of 750 global companies evaluated by TIME and its partner Statista.

Business Wire • Jul 27, 2026

AptarGroup (ATR) Expected to Beat Earnings Estimates: Should You Buy?

AptarGroup (ATR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Jul 23, 2026

Aptar Beauty Launches Next-Generation Auto-Loading Dropper Technology for Easier, More Accurate Skincare Dosing

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, announces the first commercial launch of its innovative auto-loading, dosing dropper technology called NeoDropper Autoload. Aptar's technology is featured on Dermalogica's FutureCode Booster skincare product. Designed for prestige skincare and dermocosmetic brands, this next-generation dropper packaging is intended to address consumer needs around dosage control, convenience and clean usage by supporting precision dispensing and user experience.

Business Wire • Jul 20, 2026

Aptar Declares Quarterly Dividend

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that the Board declared a quarterly cash dividend of $0.48 per share. The payment date is August 20, 2026, to stockholders of record as of July 30, 2026.

Business Wire • Jul 16, 2026

Will AptarGroup (ATR) Beat Estimates Again in Its Next Earnings Report?

AptarGroup (ATR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research • Jul 16, 2026